Exabis Library
Welcome to the e-CCO Library!
P550: Anti-mycobacterium paratuberculous therapy in Crohn’s disease: outcomes from tertiary IBD referral centres
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P550: Characterisation of hospitalised patients with ulcerative colitis treated with tofacitinib in the OCTAVE clinical programme for up to 7.8 years
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P550: Clinical features of demyelination following anti-TNFα therapy
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P550: Early 12-week ultrasound response to treatment, used as a predictor of response at 6 months in Crohn’s disease: A prospective cohort study
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P550: Management of immunomodulators and biologic agents in pregnant patients with inflammatory bowel: results from the DUMBO registry of GETECCU
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P550: Short term effects of a combined lifestyle intervention in patients with Inflammatory Bowel Disease
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P551 Combination therapy in IBD Patients: Do we need to maximise the dose of Azathioprine?
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P551: 6-Thioguanine nucleotide levels are associated with mucosal healing in patients with Crohn’s disease: A multi-centre, international study
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P551: Lack of adherence to infliximab in inflammatory bowel disease patients contributes to loss of response in Crohn’s disease.
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P551: Platelet-to-lymphocyte ratio index for non-invasive assessment of endoscopic activity in small bowel Crohn's disease: application and prospective validation.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P551: Safety and effectiveness of vedolizumab for the treatment of paediatric patients with Inflammatory Bowel Diseases
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P551: Smooth Seton® for perianal fistulas: a knot-less solution
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P551: Use of preoperative total parenteral nutrition is associated with clinical and laboratory remission in severe active Crohn’s disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P552 Withdrawal of immunomodulator medications (IM) in children with inflammatory bowel disease on combination therapy of IM and biologics
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P552: An online educational portal improves concerns of inflammatory bowel disease patients regarding pregnancy and medication
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P552: Anti-TNF Treatment and Risk of Atrial Fibrillation in Inflammatory Bowel Disease Patients
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P552: Assessing adherence to objective disease monitoring and outcomes with adalimumab in a real-world IBD cohort.
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P552: Early use of vedolizumab vs. infliximab in biologic-naive patients with ulcerative colitis: A real-world analysis of healthcare utilisation
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P552: Gastroenterologists’ perceptions on use of medical cannabis for IBD
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P552: Higher Serum Ustekinumab Levels Correlate With Higher Rates Of Steroid-Free Deep Remission And Endoscopic Healing In Patients With Inflammatory Bowel Diseases
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM